Occurrence of hyperthyroidism in patients receiving thyroid hormone.
D000293:Adolescent; D000328:Adult; D000505:Alopecia / Q000188:drug therapy; D013956:Antithyroid Agents / Q000627:therapeutic use; D005221:Fatigue / Q000188:drug therapy; D005260:Female; D006042:Goiter / Q000188:drug therapy; D006111:Graves Disease / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced*; D007456:Iodine Isotopes / Q000627:therapeutic use; D008599:Menstruation Disturbances / Q000188:drug therapy; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy; D011441:Propylthiouracil / Q000627:therapeutic use; D013963:Thyroid Hormones / Q000009:adverse effects*; D013974:Thyroxine / Q000009:adverse effects*; D014284:Triiodothyronine / Q000009:adverse effects*
D013956:Antithyroid Agents; D007456:Iodine Isotopes; D013963:Thyroid Hormones; D014284:Triiodothyronine; D011441:Propylthiouracil; D013974:Thyroxine